Literature DB >> 35419549

Ruthenium Photosensitizers for NIR PDT Require Lowest-Lying Triplet Intraligand (3IL) Excited States.

Liubov M Lifshits1, John A Roque1,2, Elamparuthi Ramasamy1, Randolph P Thummel3, Colin G Cameron1, Sherri A McFarland1.   

Abstract

A family of complexes of the type [Ru(tpbn)(IP-R)(4-pic)]Cl2 (tbpn=2,2'-(4-(tert-butyl)pyridine-2,6-diyl)bis(1,8-napthyridine); 4-pic=4-picoline; IP-R=imidazo[4,5-f][1,10]phenanthroline attached to an aromatic group R for 2-8 and H for 1) were prepared as near-infrared (NIR) absorbing coordination complexes to test whether triplet intraligand excited states (3IL) of higher energy than the lowest-lying triplet metal-to-ligand charge transfer excited states (3MLCT) could effectively generate cytotoxic singlet oxygen (1O2) and elicit in vitro photodynamic therapy (PDT) effects. Aromatic groups ranged from benzene to anthracene, with corresponding triplet state energies that were all significantly higher (approximately 3.7-1.8 eV) than the 3MLCT state estimated at 1.5 eV. Complexes 1-8 absorbed NIR light, with their longest-wavelength peak maxima occurring near 725 nm that extended out to 800 nm. The 1O2 quantum yields for the aromatic-containing compounds were extremely small (ΦΔ=0.07), with correspondingly modest in vitro photocytotoxicities. All compounds were nontoxic without a light trigger, with dark EC50 values >60 μM and most values closer to 100 or greater. EC50 values with visible light were 5-6 (PI=15-20), 7-10 (PI=8-11), and 10-15 μM (PI=6-8) in SKMEL28, A375, and B16F10 cancer cell lines, respectively. With NIR light, these values were even less: 11-16 (PI=5-9), 16-50 (PI=2-6), and 15-19 μM (PI=4-6) in SKMEL28, A375, and B16F10 cancer cell lines, respectively. While measurable, the modest activities and absence of any trend between the 3IL energies and values for ΦΔ or PI demonstrate that 3IL states with energies above the lowest-lying 3MLCT states do not contribute to the overall excited state dynamics responsible for potent PDT effects in previous studies. Lowest-lying 3MLCT states in this family of NIR-absorbing photosensitizers do not produce the requisite 1O2 for effective in vitro photocytotoxic effects, underscoring the need to install 3IL states that are lower in energy than the lowest-lying 3MLCT states in order the create potent NIR-activatable Ru(II) complexes for PDT.

Entities:  

Keywords:  Ruthenium; intraligand (IL); melanoma; metal-to-ligand charge transfer (MLCT); near-infrared (NIR); photodynamic therapy

Year:  2021        PMID: 35419549      PMCID: PMC9000368          DOI: 10.1016/j.jpap.2021.100067

Source DB:  PubMed          Journal:  J Photochem Photobiol        ISSN: 2666-4690


  41 in total

1.  Mononuclear and dinuclear complexes of isoeilatin.

Authors:  Sheba D Bergman; Israel Goldberg; Andrea Barbieri; Moshe Kol
Journal:  Inorg Chem       Date:  2005-04-04       Impact factor: 5.165

2.  Ru(II) dyads derived from 2-(1-pyrenyl)-1H-imidazo[4,5-f][1,10]phenanthroline: versatile photosensitizers for photodynamic applications.

Authors:  Mat Stephenson; Christian Reichardt; Mitch Pinto; Maria Wächtler; Tariq Sainuddin; Ge Shi; Huimin Yin; Susan Monro; Eric Sampson; Benjamin Dietzek; Sherri A McFarland
Journal:  J Phys Chem A       Date:  2014-07-01       Impact factor: 2.781

3.  Synthesis and Characterization of Ru(II) Complexes with π-Expansive Imidazophen Ligands for the Photokilling of Human Melanoma Cells.

Authors:  Goutam Ghosh; Huimin Yin; Susan M A Monro; Tariq Sainuddin; Lloyd Lapoot; Alexander Greer; Sherri A McFarland
Journal:  Photochem Photobiol       Date:  2020-01-09       Impact factor: 3.421

4.  Singlet oxygen: there is still something new under the sun, and it is better than ever.

Authors:  Peter R Ogilby
Journal:  Photochem Photobiol Sci       Date:  2010-10-21       Impact factor: 3.982

5.  Strained ruthenium metal-organic dyads as photocisplatin agents with dual action.

Authors:  Tariq Sainuddin; Mitch Pinto; Huimin Yin; Marc Hetu; Julie Colpitts; Sherri A McFarland
Journal:  J Inorg Biochem       Date:  2016-01-09       Impact factor: 4.155

Review 6.  Metal-based photosensitizers for photodynamic therapy: the future of multimodal oncology?

Authors:  Sherri A McFarland; Arkady Mandel; Roger Dumoulin-White; Gilles Gasser
Journal:  Curr Opin Chem Biol       Date:  2019-11-20       Impact factor: 8.822

7.  Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433.

Authors:  Susan Monro; Katsuya L Colón; Huimin Yin; John Roque; Prathyusha Konda; Shashi Gujar; Randolph P Thummel; Lothar Lilge; Colin G Cameron; Sherri A McFarland
Journal:  Chem Rev       Date:  2018-10-08       Impact factor: 60.622

8.  Bis[pyrrolyl Ru(ii)] triads: a new class of photosensitizers for metal-organic photodynamic therapy.

Authors:  Deborah A Smithen; Susan Monro; Mitch Pinto; John Roque; Roberto M Diaz-Rodriguez; Huimin Yin; Colin G Cameron; Alison Thompson; Sherri A McFarland
Journal:  Chem Sci       Date:  2020-10-06       Impact factor: 9.825

9.  Breaking the barrier: an osmium photosensitizer with unprecedented hypoxic phototoxicity for real world photodynamic therapy.

Authors:  John A Roque; Patrick C Barrett; Houston D Cole; Liubov M Lifshits; Ge Shi; Susan Monro; David von Dohlen; Susy Kim; Nino Russo; Gagan Deep; Colin G Cameron; Marta E Alberto; Sherri A McFarland
Journal:  Chem Sci       Date:  2020-08-03       Impact factor: 9.825

10.  NIR-Absorbing RuII Complexes Containing α-Oligothiophenes for Applications in Photodynamic Therapy.

Authors:  Liubov M Lifshits; John A Roque; Houston D Cole; Randolph P Thummel; Colin G Cameron; Sherri A McFarland
Journal:  Chembiochem       Date:  2020-09-25       Impact factor: 3.164

View more
  2 in total

1.  Remediating Desmoplasia with EGFR-Targeted Photoactivable Multi-Inhibitor Liposomes Doubles Overall Survival in Pancreatic Cancer.

Authors:  Girgis Obaid; Shazia Bano; Hanna Thomsen; Susan Callaghan; Nimit Shah; Joseph W R Swain; Wendong Jin; Xiadong Ding; Colin G Cameron; Sherri A McFarland; Juwell Wu; Mark Vangel; Svetla Stoilova-McPhie; Jie Zhao; Mari Mino-Kenudson; Charles Lin; Tayyaba Hasan
Journal:  Adv Sci (Weinh)       Date:  2022-06-24       Impact factor: 17.521

2.  Ruthenium-Locked Helical Chirality: A Barrier of Inversion and Formation of an Asymmetric Macrocycle.

Authors:  Corjan van de Griend; Johannes J van de Vijver; Maxime A Siegler; Remus T Dame; Sylvestre Bonnet
Journal:  Inorg Chem       Date:  2022-09-28       Impact factor: 5.436

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.